PROGNOSIS OF BREAST CANCER IN EUROPEAN FEMALE ADOLESCENTS AND YOUNG ADULTS (AYAs): EUROCARE-6 RETROSPECTIVE COHORT RESULTS.

Ottobre 14, 2025/da Luisa

CDK4/6 INHIBITION IN ADVANCED CHORDOMA: FINAL RESULTS OF THE NCT PMO-1601 TRIAL.

Ottobre 7, 2025/da Luisa

PRESS RELEASES OF INDUSTRY-SPONSORED CLINICAL TRIALS IN ONCOLOGY: CHARACTERISTICS, TIMING AND FINANCIAL IMPACT.

Settembre 30, 2025/da Luisa

SURVIVAL OF PATIENTS WITH LUNG ADENOCARCINOMA DIAGNOSED IN 2000, 2010, AND 2020.

Settembre 23, 2025/da Luisa

ALLIANCE AGAINST CANCER 18-20 SETTEMBRE-VERONA 10TH ANNUAL MEETING: NEW TECHNOLOGIES AND STRATEGIES TO FIGHT CANCER

Settembre 16, 2025/da Luisa

PLATELET TRANSFUSION: 2025 AABB AND ICTMG INTERNATIONAL CLINICAL PRACTICE GUIDELINES.

Settembre 16, 2025/da Luisa

UNIMI-MASTER UNIVERSITARIO DI I LIVELLO: MASTER TLSB NOVEMBRE 2025-NOVEMBRE 2026

Settembre 15, 2025/da Luisa

TRASTUZUMAB DERUXTECAN (T-DXd)+PERTUZUMAB (P) vs TAXANE+TRASTUZUMAB+PERTUZUMAB (THP) FOR FIRST-LINE (1L) TREATMENT OF PATIENTS (pts) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) ADVANCED/METASTATIC BREAST CANCER (a/mBC): INTERIM RESULTS FROM DESTINY-BREAST09

Settembre 9, 2025/da Luisa

12-13 SETTEMBRE 2025 LECCE-TERAPIE INNOVATIVE NEL CARCINOMA MAMMARIO E NELLE NEOPLASIE GINECOLOGICHE

Settembre 2, 2025/da Luisa

PERIOPERATIVE DURVALUMAB IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER.

Settembre 2, 2025/da Luisa

AIGOM-2025 CARCINOMA MAMMARIO METASTATICO: QUALI NOVITA’? WEBINAR 10 OTTOBRE 2025

Agosto 4, 2025/da Luisa

NOVEL THERAPIES FOR PANCREATIC CANCER.

Luglio 22, 2025/da Luisa
Carica di più